Berenberg Bank Analysts Give Evotec AG (EVT) a €13.00 Price Target
Evotec AG (ETR EVT) traded up 3.13% during mid-day trading on Tuesday, reaching €13.49. 35,812 shares of the company’s stock traded hands. Evotec AG has a 1-year low of €3.30 and a 1-year high of €13.60. The firm has a market cap of €1.88 billion and a PE ratio of 53.32. The firm has a 50 day moving average of €11.97 and a 200 day moving average of €8.75.
Evotec AG Company Profile
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners’ target through a range of commercial structures, including research fees, milestones and/or royalties.
Receive News & Ratings for Evotec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec AG and related companies with MarketBeat.com's FREE daily email newsletter.